ShareHub

Tesla Touts Lower EV Delivery Estimate. The Stock Is Falling.

The EV giant will likely release actual Q1 delivery figures on April 2.

Cyclone Narelle downgraded to tropical low but severe weather warnings remain for storm-ravaged WA

Flash flooding threatens the wheatbelt region and Perth, as weather system expected to continue south-east from Geraldton on SaturdayGet our breaking news em...

Why Argan Stock Was a Winner This Week | The Motley Fool

The company crushed bottom-line estimates in its final quarter of 2025.

The 1 Retirement Budgeting Mistake Too Many People Risk Making | The Motley Fool

This error could really trip you up.

Ligand Pharma CFO Sells $688K in Stock as Shares Surge 80% This Past Year. Here's What to Know | The Motley Fool

This royalty-focused biotech with a broad drug portfolio reported a notable insider sale amid strong stock performance.

This investment offers a terrific combination of likely price appreciation along with dividend income.

It was a historic stretch of time for the biotech.

As stocks sell off, here's one of the Magnificent Seven stocks I think has fallen enough to make it a buy.

Alphatec CFO Sells $986K in Stock With Shares Up 9% This Past Year. Here's What Investors Should Know | The Motley Fool

This spine-focused medtech firm, known for its surgical innovations, reported a notable insider sale amid ongoing portfolio expansion.

3 No-Brainer AI Stocks to Buy Before They Soar, According to Wall Street | The Motley Fool

Analysts think Nebius, Microsoft, and Nvidia have huge upsides.

Crinetics Director Sells 5,000 Shares With Stock Down 4%, but Here's What Matters More | The Motley Fool

This biotech specializing in endocrine therapies reported a notable insider sale as it advances clinical-stage drug candidates.

LeMaitre Vascular, a specialist in vascular medical devices, reported a notable insider sale amid strong recent share gains.

Data centers devour energy. Argan builds the power plants that feed them.

Should You Buy Lockheed Martin While It's Up 26% in 2026? | The Motley Fool

If the defense budget tops $1 trillion, Lockheed stands to make a fortune.

This annuities and life insurance provider saw a notable insider buy amid a year marked by sharp share price declines and sector headwinds.

Stoke Therapeutics Stock Up 340% as Chair Sells $174K in Shares | The Motley Fool

This biotech innovator in genetic disease therapies reported a notable insider sale amid a year of dramatic share price gains.

Ethereum and Solana Just Got a Huge Catalyst. Should You Buy Them With $1,000? | The Motley Fool

These two coins now have fewer obstacles blocking their growth.

Is Tecnoglass Stock a Buy After Energy Holdings Scooped Up Shares Worth $13.1 Million? | The Motley Fool

This architectural glass manufacturer, serving major markets across the Americas, reported a recent insider buy in official filings.

Rising oil prices are pressuring the cruise operator.

Alpha Metallurgical Resources, a major U.S. coal supplier, reported a recent insider buy following a year of strong stock performance.

Specializing in advanced semiconductor substrates, this materials supplier reported a notable insider sale amid ongoing sector demand.

Two jury verdicts highlight a new risk facing Meta.

This enterprise software firm, focused on automation and secure connectivity, reported a significant insider sale in the latest filing.

Why Six Flags Stock Fell Today | The Motley Fool

It's becoming more expensive to drive to amusement parks.

Lincoln Educational Insider Sells 8,450 Shares Amid Big Stock Surge, but Here's What Matters for Investors | The Motley Fool

Known for its career-focused education programs, this technical training provider reported a notable insider sale in its latest SEC filing.

Nike stock has collapsed in recent years, but there's a lot of turnaround potential.

Curbline CEO Sells $3 Million in Stock as Net Income Jumps to $40 Million. What Should Investors Know? | The Motley Fool

This New York retail REIT, focused on high-traffic shopping centers, reported notable insider selling amid recent sector outperformance.

Every Magnificent Seven Stock Is Down This Year. This One Is a Screaming Buy | The Motley Fool

Investors are rotating out of the Mag Seven, but there's still opportunity there.